TOP 10+ cliniche di Target therapy for lung cancer al mondo: prezzi, TOP medici e opinioni

Memorial Şişli Hospital – JCI accredited (first in Turkey) – offers targeted therapy for lung adenocarcinoma with comprehensive genetic testing. Treatment may cost around $3,000 USD, typically covering preliminary therapy planning. Extended NGS testing for RET, ROS1, MET and other mutations helps identify broader therapy options. The hospital maintains a 4.6/5 rating from 333 reviews with 91% recommendation rate.

Prof. Dr. Suleyman Alici leads the target immunotherapy program at JCI-accredited Hisar Hospital. The complete Pembrolizumab package may cost around $23,300 USD, typically covering 4 treatment courses, PET-CT if needed, lab tests, and transfers. With a multidisciplinary oncology team, the hospital treats over 500,000 international patients annually. The all-inclusive approach ensures personalized care with 15+ language support.

Memorial Bahçelievler Hospital offers targeted therapy for non-small cell lung cancer with EGFR mutation, including latest options like amivantamab. The preliminary diagnostic program may cost around 1,500 EUR, typically covering PET-CT scan, brain MRI, and up to 5 additional scans. The JCI and ISO certified hospital features Elekta Versa HD radiotherapy in a LEED Platinum eco-friendly facility. Dr. Hanna creates personalized treatment plans based on comprehensive diagnostics.

Nordwest Krankenhaus is a multi specialized medical institution, a leading hospital in Germany due to development of innovations, such as 3D ultrasound, anticancer vaccines in targeted therapy. It comprises 5 research institutes and 11 specialized centers.

Prof. Dr. Şeref Kömürcü, an ECFMG and ESMO-certified oncologist with 30+ years of experience, specializes in lung cancer treatment. The initial oncology examination may cost around 850 EUR, typically including consultation and PET CT scan. Anadolu Medical Center operates under Johns Hopkins affiliation, offering advanced diagnostics like 3T MRI and molecular analyses. Prof. Kömürcü provides comprehensive evaluations based on individual tumor characteristics.

Fuda Cancer Hospital specializes in targeted therapy for lung cancer with over 30,000 international patients treated. The hospital offers advanced minimally invasive treatments and holds JCI accreditation. Professor Niu Lizhi, President of Fuda, has performed over 10,000 cryosurgeries and pioneered NanoKnife procedures. His extensive research and leadership in cryosurgery make him one of Asia's most experienced oncologists.

Solingen Municipal Hospital/Academic Hospital of the University of Cologne is among top clinics in Germany according to Focus magazine - one of the most widely circulated German editions. Städtisches Klinikum Solingen is a certified medical institution treating over 60,000 patients per year.

Jinshazhou Hospital of Guangzhou University of Chinese Medicine is a tertiary Class-III general hospital approved by the Guangzhou Municipal Health Commission. Located in Baiyun District, Guangzhou, the 1,500-bed hospital integrates medical treatment, teaching, scientific research, and prevention.

The hospital features advanced oncology and minimally invasive treatment centers, modern laminar flow operating rooms, intensive care facilities, and internationally recognized radiotherapy technologies. It also provides multilingual medical travel services and comprehensive support for international patients.

SJD Barcelona Children's Hospital (Spain) treats patients from infancy to 18 years old. It is among the top three medical institutions in Europe and a leading center for pediatric oncology. The hospital has a dedicated Laboratory for Molecular Medicine, where innovative treatment methods are developed.

Samsung Medical Center's Comprehensive Cancer Center offers advanced target therapy for lung cancer using state-of-the-art equipment like Novalis and IGRT. Treatment typically costs around $3,100–$3,600. Prof. Keun Chil Park, MD, heads the Division of Hematology-Oncology and specializes in lung cancer treatment. He holds memberships in ASCO, AACR, ESMO, and IASLC.